9:09 AM ET
8-K
Other 8-K Filing
Sunshine Biopharma Other 8-K Filing
Sunshine Biopharma announced a reduction in the exercise price of its outstanding Series B Warrants to $1.2046. This adjustment was triggered by recent sales of common stock under the company's existing at-the-market (ATM) offering program. The price remains subject to further potential adjustments based on the terms of the warrants.